Friday, July 10, 2026

Drug profile · INN

626

626 is an FDA-listed pharmaceutical active ingredient.

NMPA: clinical trials
Patents linked 0
Pipeline programs 3
News articles 0
Drug details — 626
Class
Route
Patents
0
Programs
3
Data quality
0.70

Quick answer

626 is an FDA-listed pharmaceutical active ingredient.

Key facts

INN 626

Approval history

Authority Status Date
NMPA clinical trials

Pipeline programs

  1. 626 Phase 2 · Sunshine Guojian Pharmaceutical · Systemic Lupus Erythematosus (SLE)
  2. 626 Phase 1 · Sunshine Guojian Pharmaceutical · Healthy Subjects (HS)
  3. 626 Phase 1 · LianBio · Healthy Subjects (HS)

Frequently asked questions

What is 626?

626 is an FDA-listed pharmaceutical active ingredient.